Vycor Medical Inc (VYCO) income statement
VYCOOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.07+0.00 (0.00%)
Close on Oct 19, 2026Market cap $2.24MP/E –Yield –
Vycor Medical Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 83.4%
- Operating margin
- 2.7%
- Net margin
- -3.3%
- Return on equity, FY2025
- 1.9%
Financial strength
- Current ratio
- 0.13
- Debt to equity
- -0.03
- Debt to assets
- 16.5%
- Cash to current liabilities
- 3.2%
Valuation
- P/E ratio
- –
- Price to sales
- 1.24
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?